Dendritic Cell Therapy for Triple-Negative Breast Cancer: Research Progress, Safety and Potential Benefits
Triple-negative breast cancer (TNBC) is
diagnosed when cancer cells lack estrogen receptors, progesterone receptors and
HER2. Because these targets ar...
